These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19442087)

  • 41. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.
    Papagiannaros A; Hatziantoniou S; Dimas K; Papaioannou GT; Demetzos C
    Biomed Pharmacother; 2006 Jan; 60(1):36-42. PubMed ID: 16271845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.
    Duijsings D; Houweling M; Vaandrager AB; Mol JA; Teerds KJ
    Eur J Pharmacol; 2004 Oct; 502(3):185-93. PubMed ID: 15476744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B.
    Ménez C; Legrand P; Rosilio V; Lesieur S; Barratt G
    Mol Pharm; 2007; 4(2):281-8. PubMed ID: 17397240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of antileishmanial lipid nanocomplexes.
    Pham TT; Gueutin C; Cheron M; Abreu S; Chaminade P; Loiseau PM; Barratt G
    Biochimie; 2014 Dec; 107 Pt A():143-53. PubMed ID: 24952352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.
    Jiménez-López JM; Ríos-Marco P; Marco C; Segovia JL; Carrasco MP
    Lipids Health Dis; 2010 Mar; 9():33. PubMed ID: 20338039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
    Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy.
    Henke J; Engelmann J; Kutscher B; Nssner G; Engel J; Voegeli R; Leibfritz D
    Anticancer Res; 1999; 19(5B):4027-32. PubMed ID: 10628349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays.
    Schaider H; Seidl H; Berger MR; Hofmann-Wellenhof R; Tritthart HA; Smolle J
    Anticancer Res; 1998; 18(2A):995-8. PubMed ID: 9615753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiinvasive activity of hexadecylphosphocholine in vitro.
    Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
    Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor activity of doxorubicin encapsulated in hexadecylphosphocholine (HePC) liposomes against human xenografts on Scid mice.
    Papagiannaros A; Hatziantoniou S; Lelong-Rebel IH; Papaioannou GT; Dimas K; Demetzos C
    In Vivo; 2006; 20(1):129-35. PubMed ID: 16433041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
    Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
    Bishop FE; Dive C; Freeman S; Gescher A
    Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
    Lucas L; Hernández-Alcoceba R; Penalva V; Lacal JC
    Oncogene; 2001 Mar; 20(9):1110-7. PubMed ID: 11314048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of miltefosine with intercellular membranes of stratum corneum and biomimetic lipid vesicles.
    Alonso L; Mendanha SA; Marquezin CA; Berardi M; Ito AS; Acuña AU; Alonso A
    Int J Pharm; 2012 Sep; 434(1-2):391-8. PubMed ID: 22692081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepcidin inhibits apical iron uptake in intestinal cells.
    Mena NP; Esparza A; Tapia V; Valdés P; Núñez MT
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G192-8. PubMed ID: 17962361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
    Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
    J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Miltefosine increases lipid and protein dynamics in Leishmania amazonensis membranes at concentrations similar to those needed for cytotoxicity activity.
    Moreira RA; Mendanha SA; Fernandes KS; Matos GG; Alonso L; Dorta ML; Alonso A
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3021-8. PubMed ID: 24614380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hexadecylphosphocholine inhibits phosphatidylcholine synthesis via both the methylation of phosphatidylethanolamine and CDP-choline pathways in HepG2 cells.
    Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
    Int J Biochem Cell Biol; 2004 Jan; 36(1):153-61. PubMed ID: 14592540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Capillary gas chromatography of hexadecylphosphocholine in Caco-2T cells and cell culture media.
    Steelant WF; Bruyneel EA; Mareel MM; Van den Eeckhout EG
    Anal Biochem; 1995 May; 227(1):246-50. PubMed ID: 7668387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of two 50 kDa proteins is associated with sensitivity towards etherlipid analogues in the human leukaemia cell line HL 60.
    Berkovic D; Hiddemann W; Kuduz J; Fleer EA
    Eur J Cancer; 1997 Oct; 33(11):1875-80. PubMed ID: 9470850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.